Cash Interest Paid - Maat Pharma SA (PAR:MAAT) - Alpha Spread
M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.3 EUR 2.24% Market Closed
Market Cap: 101.4m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Maat Pharma SA
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maat Pharma SA
Cash Interest Paid Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Cash Interest Paid Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
M
Maat Pharma SA
PAR:MAAT
Cash Interest Paid
€179k
CAGR 3-Years
53%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Cash Interest Paid
€17.9m
CAGR 3-Years
39%
CAGR 5-Years
38%
CAGR 10-Years
27%
Nanobiotix SA
PAR:NANO
Cash Interest Paid
€7m
CAGR 3-Years
115%
CAGR 5-Years
371%
CAGR 10-Years
92%
Innate Pharma SA
PAR:IPH
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genfit SA
NASDAQ:GNFT
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Maat Pharma SA's Cash Interest Paid?
Cash Interest Paid
179k EUR

Based on the financial report for Dec 31, 2023, Maat Pharma SA's Cash Interest Paid amounts to 179k EUR.

What is Maat Pharma SA's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
17%

Over the last year, the Cash Interest Paid growth was 19%. The average annual Cash Interest Paid growth rates for Maat Pharma SA have been 53% over the past three years , 17% over the past five years .

Back to Top